FDA awards Isarna orphan drug designation for ISTH0036 to improve glaucoma treatment outcome
10 June 2015 | By Victoria White
Isarna Therapeutics has announced that the Food and Drug Administration (FDA) has granted orphan drug designation for ISTH0036...